Abdi İbrahim is a leading Turkish pharmaceutical company engaged in the development, manufacturing, and marketing of prescription (Rx) and over-the-counter (OTC) products across various therapeutic areas. In addition to its own broad portfolio, the company provides high-quality Contract Manufacturing Organization (CMO) services to more than 35 partners, offering end-to-end solutions from technology transfer to commercial production under EU GMP standards

Company (Headquarters):

Turkey

Types of Drugs Manufactured:

Small Molecule;Biologics

CDMO Services:

Drug Product/FDF;Packaging(Commercial);Analytical Development;Packaging (Clinical);Supply Chain Logistics

CDMO Number of Facilities:

3

High Potent Products capabilities:

OEB 3 Medium Potency;OEB 4-5 Highly Potent APIs (HPAPIs);OEB >5 Ultra high potency

Facilities Location:

Europe;Africa;Central/Western Asia

Manufacturing Technologies:

Blow-Fill-Seal (BFS);Cartridges;Creams/Gels/Ointments;Inhalers;Lyophilized amps/vials;Oral Liquids;Pre-Filled Syringes (PFS);Sterile Vials;Tablets/Capsules